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ABSTRACT
To determine how different methods of normalizing for global cerebral blood flow
(gCBF) affect image quality and sensitivity to cortical activation, pulsed arterial
spin labeling (pASL) scans obtained during a visual task were normalized by either
additive or multiplicative normalization of modal gCBF. Normalization by either
method increased the statistical significance of cortical activation by a visual
stimulus. However, image quality was superior with additive normalization, whether
judged by intensity histograms or by reduced variability within gray and white
matter.
Subjects Neuroscience, Neurology
Keywords Cerebral blood flow, ASL, Arterial spin labeling, fMRI,

Functional magnetic resonance imaging, Cerebral blood flow measurement, Parkinson’s disease
Submitted 31 December 2014
Accepted 20 February 2015
Published 17 March 2015
Corresponding author
Kevin J. Black, kevin@WUSTL.edu
Academic editor
Darren Gitelman
Additional Information and
Declarations can be found on
page 10
DOI 10.7717/peerj.834
Copyright
2015 Stewart et al.
Distributed under
Creative Commons CC-BY 4.0
OPEN ACCESS

INTRODUCTION
Blood flow imaging of the brain has brought insights to neuroscience for over 50 years
(Taber, Black & Hurley, 2005). Whole-brain, or global, cerebral blood flow (gCBF)
calculated from blood flow images can be the outcome measure of interest, or can permit
correction for gCBF fluctuations that complicate identifying or interpreting relative
changes in regional blood flow (rCBF) (Black et al., 2002).
Readers more familiar with BOLD (blood oxygen level dependent) imaging must take
care not to confuse (a) gCBF calculation and correction with (b) correction for global
signal in statistical analysis of BOLD images, a procedure that differs in several important
ways. Unlike typical BOLD methods, CBF is a physical attribute with physiologically
meaningful values. The typical distribution of CBF across the healthy human brain is well
established by a variety of techniques, with a mean of about 50 ml of blood per 100 g of
brain tissue per minute (50 ml/hg/min; solid curve in Fig. 1) (Lassen, 1985; Ramsay et al.,
1993). Therefore, any CBF imaging method can be verified by quantitative comparison to
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Figure 1 Typical brain rCBF values and the effects of multiplication or addition. Histogram of typical
rCBF values from resting human brain (solid line). Histograms are also shown for the voxelwise product
of that image with 1.3 (dotted line) and for the difference image after subtracting 20 ml/hg/min from
each voxel (dashed line).

these standard values. As a consequence, voxels within a single CBF image are expected
to demonstrate internally consistent values (e.g., gray matter CBF is similar throughout
the brain), again unlike most BOLD methods. Determining global CBF is thus a method
aimed primarily at calibrating the voxels within a single CBF image, not a method for
accounting for fluctuations at a single voxel across a time series of BOLD images. Another
way of saying this is that gCBF computation is aimed at finding a numerical value with
physical units, rather than the value of a test statistic.
Early in vivo measures of CBF in humans used PET to collect an autoradiographic image
of radioactive counts over a defined interval of time (Herscovitch, Markham & Raichle,
1983). Measuring arterial radioactivity over time allowed calculation of quantitative rCBF
from the PET image of radioactivity concentration (Herscovitch, Markham & Raichle, 1983;
Raichle et al., 1983). Changes in rCBF then could be calculated directly by subtracting two
different PET images of rCBF (Ramsay et al., 1993). However, arterial sampling required
an invasive measurement and added statistical noise. Fortunately, the quantitative CBF
image was essentially a scalar multiple of the PET radioactivity concentration image, so
when gCBF was not expected to change substantially between two CBF images, one could
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multiplicatively scale the raw images to an arbitrary gCBF value before subtraction, and
many PET activation studies did just that to account for modest fluctuations of gCBF
between PET scans without arterial sampling for quantification (Fox et al., 1984).
In 2008 we performed an ASL pharmacological challenge MRI study in Parkinson
disease (PD) (Black et al., 2010b). The original analysis used multiplicatively scaled images
based on our experience with PET blood flow imaging (Black et al., 2002). However,
when we revisited those data recently for a new analysis (Stewart et al., 2014), we sought
to improve the quality of the scaled images. Frequency histograms of the perfusion
images appeared to differ from the typical rCBF distribution by a fixed shift (dashed
line in Fig. 1) rather than by a similar change in mean and dispersion, as one would see
with multiplicatively scaled images (dotted line in Fig. 1). Returning to basic principles
suggested an explanation. Unlike PET CBF, perfusion images from arterial spin labeling
(ASL) MRI are created by subtracting two images obtained a few seconds apart, one in
which arterial blood flowing into the brain has been labeled using a spatially limited radio
frequency pulse (“tag”) and a second image without that label (“control”) (Wang et al.,
2003). Subtraction creates the possibility of a negative or positive additive bias across a CBF
image, in which case additive rather than multiplicative correction may better equalize the
intensity of two ASL CBF images.
We test that hypothesis here using several criteria to assess image quality.

MATERIAL & METHODS
Study participants
Twenty-one nondemented, nondepressed, ambulatory adults age 40–75 with idiopathic
PD, treated with a stable dose of levodopa but no dopamine agonists, participated in the
study. Detailed inclusion and exclusion criteria and subject characteristics were reported
previously (Black et al., 2010a; Black et al., 2010b). Subjects were enrolled in a Phase
2a dose-finding study (Black et al., 2010b), but here we use only data acquired on the
placebo day when subjects were in the “practical off state” (i.e., no antiparkinsonian
medications for at least 9 h). The study was approved by the Washington University
Human Research Protection Office (IRB approval # 08-0059), and all subjects provided
written documentation of informed consent prior to participation.

Subject behavior
Each subject had two perfusion MRI scans while fixating a central crosshair surrounded
by a circular checkerboard reversing at 8 Hz, and two control visual fixation scans with the
crosshair but no checkerboard.

MR image acquisition
All MRI data were acquired on a Siemens 3T Tim Trio with matrix head coil. ASL
images were acquired with the commercial Siemens pulsed arterial spin labeling (pASL)
sequence (Wang et al., 2003). Fifteen transverse echo-planar readout slices were acquired
with center-to-center slice distance 7.5 mm, 64 × 64 voxels in plane with dimensions
(3.4375 mm)2 , repetition time (TR) 2.6 s, echo time (TE) 13.0 ms, and flip angle 90◦ . An
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M0 image was followed by 31 tag-control pairs for a total acquisition time for each ASL
“scan” of 2.73 min.
Brain structure was assessed from sagittal MP-RAGE acquisitions with voxel size
(1.0 mm)3 , TR = 2.4 s, TE = 3.08 ms, TI = 1,000 ms, flip angle = 8◦ . The structural
images for each subject were inspected visually, images of lower quality were rejected, and
the remaining 1–4 MP–RAGE images for each subject were mutually registered.

Image registration and creation of CBF images
The 63 frames of the ASL run were rigidly aligned using a validated method (Black et al.,
2001) and summed to facilitate later alignment steps. Each frame was smoothed using
a Gaussian filter with 7.35 mm kernel (FWHM), and cerebral blood flow (CBF) was
computed in each voxel for each tag-control pair as described (Wang et al., 2003). The
summed, aligned EPI images from each run were mutually aligned within each subject
and summed across runs, and the resulting image was affine registered to a target image
in Talairach and Tournoux space made using validated methods from the structural MR
images from these subjects (Black et al., 2004). The products of the registration matrix
from this step and the matrices from the within-run mutual registration step were used
to resample the 31 tag-control pair CBF images from each run into atlas space in a single
resampling step. A whole-brain binary image was created from the atlas-space structural
target image, and all analyses below included only the CBF image voxels corresponding to
voxels within this mask image.
To minimize motion-related artifact we removed tag–control pairs from all further
analyses if framewise displacement in either EPI image exceeded 0.9 mm as defined by
Siegel et al. (2014). The remaining CBF images in atlas space were averaged to create a single
atlas-registered CBF image for each ASL run. One subject’s data was excluded from further
analysis because over half of the frame pairs were removed due to head motion.

Image intensity correction
Estimating modal CBF image intensity
We evaluated each CBF image independently for each of the 4 scans in each subject. The
image intensity histograms were constructed with bins 1 unit wide, so were not smooth.
We chose to normalize image intensity based on the idealized peak of this distribution
(which if there were no noise would be the mode, i.e., the most common voxel intensity
in the brain) (Ojemann et al., 1997). Specifically, the method of least squares was used to
identify the vertex of the parabola that best fit the histogram using voxels within 70% of the
mode bin (Fig. 2).
Additive and multiplicative intensity correction
Each input image was corrected in two ways: multiplicatively (multiplying every voxel
in the image by 50/mode), and additively (adding 50-mode to every voxel), so that the
idealized modal CBF for every corrected image was 50 (nominal units mL/hg/min).

Stewart et al. (2015), PeerJ, DOI 10.7717/peerj.834

4/13

Figure 2 Determining the idealized mode. The figure shows the frequency histogram for one of the
CBF images. With this bin width, the true mode falls at 32 (frequency = 898, bin including all voxels with
values 31.5–32.5), but the mean of the distribution and the vertex of the parabola shown (the idealized
mode) both fall at 35.0.

Defining volumes of interest
Gray matter (GM), white matter (WM) and visual cortex volumes of interest (VOIs),
excluding CSF regions, were defined from each subject’s high-resolution MP-RAGE image
by FreeSurfer (version 5.3, http://surfer.nmr.mgh.harvard.edu) (Desikan et al., 2006).
VOIs were limited to voxels that were represented in every image in every subject; this step
excluded much of the inferior occipital cortex in the visual cortex VOI (Black et al., 2010b).
We also used the thalamic VOIs previously defined in our drug study (Black et al., 2010b).

Statistical analysis
To determine the effect of gCBF normalization on task effect, all statistical analyses were
performed in triplicate, one for each set of images: uncorrected (before removing the gCBF
effect), multiplicatively normalized, and additively corrected.
Image quality analysis
Using only the fixation scans, the mean rCBF and its variability in the GM, thalamic and
WM VOIs was determined. The gray to white matter CBF ratio was also calculated.
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VOI analysis
To determine the change in rCBF in a VOI with visual stimulation, the mean CBF across all
voxels in the VOI from the fixation scans was subtracted from the corresponding mean in
the task scans. Statistical significance was assessed with paired t tests.
Statistical images
To identify regions activated by the visual task, we used a mixed-effects approach. First, for
each study subject, changes in rCBF were identified using SPM12b software (www.fil.ion.
ucl.ac.uk/spm/) and a voxelwise general linear model that included task (checkerboard)
versus control (fixation). The task contrast was used to generate an image of the weighted
parameter estimate for each subject. These single-subject contrast images were used as
input for a second SPM analysis using a voxelwise general linear model that included
a covariate for subject age and a factor for sex. Statistical inference was performed at
each voxel with a one-sample t test (i.e., testing whether the task contrast images are
significantly less than or greater than zero, across subjects). After thresholding at p = 0.001,
multiple comparisons correction was performed with the cluster false discovery rate set
at p = 0.05. Approximate anatomical locations of peaks in the statistical images were
provided by the Talairach Daemon client (www.talairach.org) (Lancaster et al., 2000).

RESULTS
We assessed the effect of additive or multiplicative intensity equalization in several ways:
by examining the voxel intensity distribution (by frequency histogram), by judging image
quality visually, by the variability of voxel intensity within the GM and WM, and by the
suitability of each set of images for detecting appropriate brain activation with visual
stimulation.

Voxel intensity distribution (histogram)
The idealized mode ± SD for the original CBF images was 33.36 ± 7.30. The original
CBF images contained a reasonable distribution of voxel intensities except that many
of them appeared shifted leftwards to varying degrees, so that many voxels in the brain
had physiologically impossible negative values (the 3 curves in the histogram in Fig. 3A
reflect all brain voxels from 3 successive ASL images from the same subject; a transverse
section from each of these images is shown to the right of the histogram). Multiplicative
normalization of course produced an image with an equal fraction of negative voxel values,
though the normalized image’s mode was now 50 (histograms in Fig. 3B). Additive
normalization produced a voxel intensity distribution that reflects the physiological
expectation. In addition, it much more accurately matches the intensity distribution
widths across the normalized images (histograms in Fig. 3C).

Image quality
Images normalized additively (Fig. 3C) appear to show more uniform voxels within the
GM and WM. To corroborate this quantitatively, we determined the variability in the GM
and WM both between subjects and within subjects, using scans from the fixation task
only.
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Figure 3 Additive intensity normalization improves pASL image quality. The effect of multiplicative or additive intensity normalization on 3
ASL scans (represented by red, blue and green) from one single subject: (A) before normalization, (B) after multiplicative normalization, (C) after
additive normalization. The histograms show the frequency of the voxel values across the brain (i.e., within an anatomically-defined brain mask
only) for each of 3 sequential scans. The same transverse slice in atlas space from the 3 sequential scans is also shown; scan 1 (blue), scan 2 (red) and
scan 3 (green). The grayscale range is set at 0–100 ml/hg/min, a range that reasonably reflects true physiological values, except for the images before
normalization (A), for which the range is set at 0–75 ml/hg/min because otherwise the structure in some of the images would be obscured.

Across subjects, the mean GM intensities are more similar in additively normalized
scans (coefficient of variation [CV] = 0.145) as compared to non-normalized (CV
= 0.194) or multiplicatively normalized scans (CV = 0.266). Within the GM, the
thalamic VOI also had mean intensities more similar in additively normalized scans
(coefficient of variation [CV] = 0.0093) as compared to non-normalized (CV = 0.154)
or multiplicatively normalized scans (CV = 0.167). The WM intensities are more similar in
additively normalized scans (CV =0.158; non-normalized CV = 0.206, multiplicatively
normalized scans CV = 0.263). The GM:WM ratio is more similar across subjects
after additive normalization (CV =0.056; non-normalized CV = 0.074, multiplicatively
normalized CV = 0.072) (Table 1).
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Table 1 Variability across subjects of mean GM, thalamus and WM rCBF.

Mean GM rCBF (SD, CV)a
Mean Thalamus rCBF (SD, CV)a
Mean WM rCBF (SD, CV)a
Mean GM:WM ratio (SD, CV)

Non-normalized
images

Multiplicatively
normalized

Additively
normalized

38.78 (7.51, 0.194)
54.80 (8.42, 0.154)
27.56 (5.68, 0.206)
1.416 (0.104, 0.074)

62.02 (16.47, 0.266)
84.66 (14.10, 0.167)
43.85 (11.54, 0.263)
1.418 (0.102, 0.072)

55.89 (8.11, 0.145)
71.41 (6.67, 0.093)
44.67 (7.06, 0.159)
1.256 (0.070, 0.056)

Notes.
a
Nominal units ml/hg/min

Table 2 rCBF changes in visual cortex and WM VOIs with visual stimulation.

Mean change in rCBF (SD, CV) in
visual cortex regiona
p
Mean change in rCBF (SD, CV)
in white matter regiona
p

Non-normalized
images

Multiplicatively
normalized

Additively
normalized

17.70 (13.88, 0.784)

29.83 (18.91, 0.634)

18.15 (13.37, 0.737)

1.70 × 10−5
1.07 (3.23, 3.01 )

1.03 × 10−6
2.85 (5.99, 2.10)

7.72 × 10−6
1.53 (3.47, 2.28)

0.15

0.05

0.06

Notes.
a
Nominal units ml/hg/min. Note that the mean changes are not strictly comparable between methods because of the
multiplication. Hence we provide SD and p values for comparison.

Task activation: a priori volume of interest
We examined the effect of visual stimulation in the partial visual cortex VOI (intended as a
positive control) and in the WM VOI (intended as a negative control). With this substantial
visual stimulus, the signal is detected even without normalization (visual cortex VOI,
p = 1.70 × 10−5 , paired t test), but the statistical significance of the change is greater in
either set of normalized images (multiplicative normalization, p = 1.03 × 10−6 , additive
normalization, p = 7.72 × 10−6 ). The mean change in rCBF in the visual cortex VOI
increased when the images were multiplied, but was always >10 times higher than the
change in the WM control VOI (Table 2).

Task activation: statistical image
Similarly to the VOI analysis, with this substantial visual stimulus, SPM analyses of visual
stimulation identified significant occipital cortex activation even without normalization,
though normalization increased the peak t and the volume of significant clusters (Fig. 4
and Table 3). For all 3 analyses, the peak t value occurred in the occipital lobe, in
Brodmann area 17 or 18. There were no significant clusters of deactivation with any of
the analyses.

DISCUSSION
Additive normalization of gCBF is superior to multiplicative normalization for this pASL
technique, judged by image intensity distributions and by homogeneity within gray matter
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Figure 4 SPM regions of activation. Top row: before normalization with (A) sagittal, (B) coronal and (C)
axial slices; middle row: after multiplicative normalization (D) sagittal, (E) coronal and (F) axial slices;
bottom row: after additive normalization with (G) sagittal, (H) coronal and (I) axial slices. The lower half
of occipital cortex was excluded from this analysis due to incomplete superior-inferior coverage in some
subjects (see Methods: Defining volumes of interest).

and white matter. Multiplicative scaling increases the variability in GM and WM, whereas
additive normalization improves image quality and reduces variability between subjects.
We previously found that correcting for gCBF improved task signal in ASL in young,
healthy volunteers (Black et al., 2008; Henniger et al., 2009). The present report extends
those findings to patients with Parkinson disease. Normalizing scans for variability
in gCBF improves detection of statistically significant activations from a visual task,
whether analyzed using an anatomically-defined visual cortex VOI or by whole-brain
SPM. Although noise properties improve to a greater extent with additive scaling, either

Stewart et al. (2015), PeerJ, DOI 10.7717/peerj.834

9/13

Table 3 Activation by a visual stimulus: SPM analyses.

Peak t (17 d.f.)
Location of peak
Cluster volume, voxels (ml)
p (FDR)
Peak t for 2nd significant cluster
Location of peak
Cluster volume, voxels (ml)
p (FDR)

Non-normalized
images

Multiplicatively
normalized

Additively
normalized

6.13
−8, −93, 6
119 (3.2)
<0.0005
5.59
26, −87, 9
247 (6.7)
<0.0005

7.36
4, −81, 0
369 (10.0)
<0.0005

6.48
−8, −93, 6
447 (12.1)
<0.0005

additive or multiplicative scaling permits identification of rCBF responses to a strong
visual stimulus.
The reader familiar with ASL should note a different and potentially confusing use of the
term “global.” Before calculating CBF, several pre-processing quality improvement steps
are applied to the EPI images to address signal artifacts caused by head movement or MR
signal drift over time within an ASL run. Wang (2012) used a general linear model and
global EPI signal intensity (defined by voxels above an arbitrary intensity threshold) to
account for such artifactual signal changes. We chose to address these issues using methods
developed and validated at our institution; for instance, we removed motion-contaminated
frames (Siegel et al., 2014) rather than modeling the consequent artifact. Again, please
note that Wang’s within-run global signal variable, applied separately at each voxel, is
quite different from the global (whole-brain) single-scan measurement of CBF compared
between runs in this communication.
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